Effects of rosiglitazone on global ischemia-induced hippocampal injury and expression of mitochondrial uncoupling protein 2

Biochemical and Biophysical Research Communications

Volumn 351, Issue 1, 2006, Pages 198-203

  Chen, Shang Der ^a   Wu, Hsin Yi ^b   Yang, Ding I ^c   Lee, Su Ying ^a   Shaw, Fu Zen ^d   Lin, Tsu Kung ^a   Liou, Chia Wei ^a   Chuang, Yao Chung ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Global ischemia; Hippocampus; Mitochondria; Peroxisome proliferator activated receptor ; Rosiglitazone; Uncoupling protein 2

Indexed keywords

ROSIGLITAZONE; UNCOUPLING PROTEIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFECT; HIPPOCAMPUS; LIGAND BINDING; LIPID PEROXIDATION; MALE; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; HIPPOCAMPUS; ION CHANNELS; ISCHEMIC ATTACK, TRANSIENT; MALE; MITOCHONDRIAL PROTEINS; PPAR GAMMA; RATS; RATS, SPRAGUE-DAWLEY; THIAZOLIDINEDIONES;

EID: 33750374561     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.10.017     Document Type: Article

References (37)

1. Petito C.K., Feldmann E., Pulsinelli W.A., and Plum F. Delayed hippocampal damage in humans following cardiorespiratory arrest. Neurology 37 (1987) 1281-1286
2. Pulsinelli W.A., Brierley J.B., and Plum F. Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann. Neurol. 11 (1982) 491-498
3. Smith M.L., Auer R.N., and Siesjo B.K. The density and distribution of ischemic brain injury in the rat following 2-10 min of forebrain ischemia. Acta Neuropathol. 64 (1984) 319-332
4. Raha S., McEachern G.E., Myint A.T., and Robinson B.H. Superoxides from mitochondrial complex III: the role of manganese superoxide dismutase. Free Radic. Biol. Med. 29 (2000) 170-180
5. Gniadecki R., Thorn T., Vicanova J., Petersen A., and Wulf H.C. Role of mitochondria in ultraviolet-induced oxidative stress. J. Cell. Biochem. 80 (2000) 216-222
6. Cadenas E., and Davies K.J. Mitochondrial free radical generation, oxidative stress, and aging. Free Radic. Biol. Med. 29 (2000) 222-230
7. Kang D., and Hamasaki N. Alterations of mitochondrial DNA in common diseases and disease states: aging, neurodegeneration, heart failure, diabetes, and cancer. Curr. Med. Chem. 12 (2005) 429-441
8. Hayashi T., Saito A., Okuno S., Ferrand-Drake M., Dodd R.L., Nishi T., Maier C.M., Kinouchi H., and Chan P.H. Oxidative damage to the endoplasmic reticulum is implicated in ischemic neuronal cell death. J. Cereb. Blood Flow Metab. 23 (2003) 1117-1128
9. Avshalumov M.V., and Rice M.E. NMDA receptor activation mediates hydrogen peroxide-induced pathophysiology in rat hippocampal slices. J. Neurophysiol. 87 (2002) 2896-2903
10. Kim-Han J.S., and Dugan L.L. Mitochondrial uncoupling proteins in the central nervous system. Antioxid. Redox Signal. 7 (2005) 1173-1181
11. Arsenijevic D., Onuma H., Pecqueur C., Raimbault S., Manning B.S., Miroux B., Couplan E., Alves-Guerra M.C., Goubern M., Surwit R., Bouillaud F., Richard D., Collins S., and Ricquier D. Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production. Nat. Genet. 26 (2000) 435-439
12. Negre-Salvayre A., Hirtz C., Carrera G., Cazenave R., Troly M., Salvayre R., Penicaud L., and Casteilla L. A role for uncoupling protein-2 as a regulator of mitochondrial hydrogen peroxide generation. FASEB J. 11 (1997) 809-815
13. Jezek P., and Hlavata L. Mitochondria in homeostasis of reactive oxygen species in cell, tissues, and organism. Int. J. Biochem. Cell Biol. 37 (2005) 2478-2503
14. Mattiasson G., Shamloo M., Gido G., Mathi K., Tomasevic G., Yi S., Warden C.H., Castilho R.F., Melcher T., Gonzalez-Zulueta M., Nikolich K., and Wieloch T. Uncoupling protein-2 prevents neuronal death and diminishes brain dysfunction after stroke and brain trauma. Nat. Med. 9 (2003) 1062-1068
15. Sullivan P.G., Dube C., Dorenbos K., Steward O., and Baram T.Z. Mitochondrial uncoupling protein-2 protects the immature brain from excitotoxic neuronal death. Ann. Neurol. 53 (2003) 711-717
16. Diano S., Matthews R.T., Patrylo P., Yang L., Beal M.F., Barnstable C.J., and Horvath T.L. Uncoupling protein 2 prevents neuronal death including that occurring during seizures: a mechanism for preconditioning. Endocrinology 144 (2003) 5014-5021
17. Chinetti G., Fruchart J.C., and Staels B. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflamm. Res. 49 (2000) 497-505
18. Delerive P., Fruchart J.C., and Staels B. Peroxisome proliferator-activated receptors in inflammation control. J. Endocrinol. 169 (2001) 453-459
19. Ricote M., Li A.C., Willson T.M., Kelly C.J., and Glass C.K. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391 (1998) 79-82
20. Kelly L.J., Vicario P.P., Thompson G.M., Candelore M.R., Doebber T.W., Ventre J., Wu M.S., Meurer R., Forrest M.J., Conner M.W., Cascieri M.A., and Moller D.E. Peroxisome proliferator-activated receptors gamma and alpha mediate in vivo regulation of uncoupling protein (UCP-1, UCP-2, UCP-3) gene expression. Endocrinology 139 (1998) 4920-4927
21. Patane G., Anello M., Piro S., Vigneri R., Purrello F., and Rabuazzo A.M. Role of ATP production and uncoupling protein-2 in the insulin secretory defect induced by chronic exposure to high glucose or free fatty acids and effects of peroxisome proliferator-activated receptor-gamma inhibition. Diabetes 51 (2002) 2749-2756
22. Sugawara T., Kawase M., Lewen A., Noshita N., Gasche Y., Fujimura M., and Chan P.H. Effect of hypotension severity on hippocampal CA1 neurons in a rat global ischemia model. Brain Res. 877 (2000) 281-287
23. Chuang Y.C., Tsai J.L., Chang A.Y., Chan J.Y., Liou C.W., and Chan S.H. Dysfunction of the mitochondrial respiratory chain in the rostral ventrolateral medulla during experimental endotoxemia in the rat. J. Biomed. Sci. 9 (2002) 542-548
24. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
25. Gerard-Monnier D., Erdelmeier I., Regnard K., Moze-Henry N., Yadan J.C., and Chaudiere J. Reactions of 1-methyl-2-phenylindole with malondialdehyde and 4-hydroxyalkenals. Analytical applications to a colorimetric assay of lipid peroxidation. Chem. Res. Toxicol. 11 (1998) 1176-1183
26. Nakajima A., Wada K., Miki H., Kubota N., Nakajima N., Terauchi Y., Ohnishi S., Saubermann L.J., Kadowaki T., Blumberg R.S., Nagai R., and Matsuhashi N. Endogenous PPAR gamma mediates anti-inflammatory activity in murine ischemia-reperfusion injury. Gastroenterology 120 (2001) 460-469
27. Sivarajah A., Chatterjee P.K., Patel N.S., Todorovic Z., Hattori Y., Brown P.A., Stewart K.N., Mota-Filipe H., Cuzzocrea S., and Thiemermann C. Agonists of peroxisome-proliferator activated receptor-gamma reduce renal ischemia/reperfusion injury. Am. J. Nephrol. 23 (2003) 267-276
28. Khandoudi N., Delerive P., Berrebi-Bertrand I., Buckingham R.E., Staels B., and Bril A. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma, inhibits the Jun NH(2)-terminal kinase/activating protein 1 pathway and protects the heart from ischemia/reperfusion injury. Diabetes 51 (2002) 1507-1514
29. Esterbauer H., Schaur R.J., and Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11 (1991) 81-128
30. Won M.H., Kang T.C., Jeon G.S., Lee J.C., Kim D.Y., Choi E.M., Lee K.H., Choi C.D., Chung M.H., and Cho S.S. Immunohistochemical detection of oxidative DNA damage induced by ischemia-reperfusion insults in gerbil hippocampus in vivo. Brain Res. 836 (1999) 70-78
31. Mizuno T., Miura-Suzuki T., Yamashita H., and Mori N. Distinct regulation of brain mitochondrial carrier protein-1 and uncoupling protein-2 genes in the rat brain during cold exposure and aging. Biochem. Biophys. Res. Commun. 278 (2000) 691-697
32. Shimazu T., Inoue I., Araki N., Asano Y., Sawada M., Furuya D., Nagoya H., and Greenberg J.H. A peroxisome proliferator-activated receptor-gamma agonist reduces infarct size in transient but not in permanent ischemia. Stroke 36 (2005) 353-359
33. Zhao Y., Patzer A., Herdegen T., Gohlke P., and Culman J. Activation of cerebral peroxisome proliferator-activated receptors gamma promotes neuroprotection by attenuation of neuronal cyclooxygenase-2 overexpression after focal cerebral ischemia in rats. FASEB J. 20 (2006) 1162-1175
34. 2-dependent modulation of mitochondrial fatty acid oxidation. J. Biol. Chem. 276 (2001) 27605-27612
35. Razeghi P., Young M.E., Abbasi S., and Taegtmeyer H. Hypoxia in vivo decreases peroxisome proliferator-activated receptor alpha-regulated gene expression in rat heart. Biochem. Biophys. Res. Commun. 287 (2001) 5-10
36. Villegas I., Martin A.R., Toma W., and de la Lastra C.A. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, protects against gastric ischemia-reperfusion damage in rats: role of oxygen free radicals generation. Eur. J. Pharmacol. 505 (2004) 195-203
37. Liu H.R., Tao L., Gao E., Lopez B.L., Christopher T.A., Willette R.N., Ohlstein E.H., Yue T.L., and Ma X.L. Anti-apoptotic effects of rosiglitazone in hypercholesterolemic rabbits subjected to myocardial ischemia and reperfusion. Cardiovasc. Res. 62 (2004) 135-144